PainReform Ltd. (PRFX) vs Sunshine Biopharma, Inc. (SBFM)
- PainReform Ltd. PRFX 0.81 −4.71%
- Sunshine Biopharma, Inc. SBFM 0.22 −4.35%
PainReform Ltd. and Sunshine Biopharma, Inc. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $2.6M against $990.0K — 2.6× the size. PainReform Ltd. has the higher net margin (0.00% vs −16.5%) and the higher return on invested capital (0.00% vs −26.7%). Across the 14 metrics below, PainReform Ltd. leads on 10 and Sunshine Biopharma, Inc. on 4.
Valuation
| Metric | PRFX | SBFM | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 19.25 |
| P/S | n/m | 0.01 | 2.11 |
| P/B | 0.00 | 0.01 | 1.78 |
| Price to free cash flow | n/m | n/m | 16.14 |
| EV/EBITDA | 0.97 | 2.38 | 12.58 |
| EV/Sales | n/m | (0.33) | 2.73 |
| Earnings yield | (73,121.23%) | (4,613.64%) | (4.38%) |
| Free cash flow yield | (95,565.78%) | (1,843.25%) | 0.00% |
Profitability
| Metric | PRFX | SBFM | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 0.00% | 30.30% | 53.94% |
| Operating margin | 0.00% | (16.65%) | 0.00% |
| Net margin | 0.00% | (16.50%) | 0.00% |
| Free cash flow margin | 0.00% | (15.66%) | 0.00% |
| Return on equity | 0.00% | (21.93%) | (0.40%) |
| Return on assets | 0.00% | (17.78%) | (3.32%) |
| Return on invested capital | 0.00% | (26.67%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack